Medical Lead, Chronic Lymphocytic Leukemia

One of the world's leading pharmaceutical companies is seeking several passionate, forward-thinking individuals to step into key roles in their US Medical Affairs team. This globally-established company is known for its commitment to revolutionizing healthcare through the power of scientific innovation, state-of-the-art technology, and visionary partnerships.

Their three guiding pillars - Science and Innovation, Growth and Therapy Area Leadership, and People and Sustainability - showcase their commitment to not only enhancing patient care but also championing environmental protection and ethical practices. These exciting roles are based in Gaithersburg, Maryland, one of their key operational hubs in the United States.

These exciting roles are based in Gaithersburg, Maryland, one of their key operational hubs in the United States.

Role Overview:

As the Medical Lead for Chronic Lymphocytic Leukemia, you will:

• Oversee US local trial activities, encompassing trial design, medical guidance, data interpretation, and the implementation of compassionate use strategies.
• Ensure medical precision and a balanced perspective in promotional and educational materials, for both internal and external dissemination.
• Contribute medical insights to the brand strategy as a central member of the Core Medical Team, emphasizing Chronic Lymphocytic Leukemia (CLL).
• Build and nurture relationships with strategic partners, including payer and provider groups, along with authorities in the therapy domain.
• Spearhead the organization and engagement in national and regional medical advisory boards.
• Offer medical insights for global Phase III or Life Cycle Management (LCM) programs.

Key Qualifications:

• Graduation from an accredited medical school with M.D., D.O., PharmD, Ph.D., or equivalent degrees, with active medical or professional licensing preferred.
• Extensive experience with pharmaceutical drug development and Medical/Scientific Affairs experience.
• Board certification/eligibility in internal medicine, preferably Hematology or Oncology.
• Strong leadership and organizational capabilities with experience in line management.
• Comprehensive grasp of drug development, pharmaceutical market support, Hematology/Oncology, and evolving U.S. payer and provider landscapes.
• Familiarity with OPDP, PhRMA code, and pivotal industry regulations; experience in clinical research, and foundations in biostatistics and epidemiology is a plus.